1-羟基-环戊甲酸 | 16841-19-3

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 1-羟基-环戊甲酸
• 中文别名: 1-羟基-1-环戊基甲酸；1-羟基环戊烷羧酸
• 英文名称: 1-hydroxy-cyclopentanecarboxylic acid
• 英文别名: 1-hydroxycyclopentane-1-carboxylic acid；1-Hydroxy-cyclopentan-carbonsaeure-(1)；α-hydroxycyclopentanecarboxylic acid；1-Hydroxycyclopentanecarboxylic acid
• CAS: 16841-19-3
• 化学式: C₆H₁₀O₃
• mdl: MFCD00045414
• 分子量: 130.144
• InChiKey: JJABOWZNFOCHMN-UHFFFAOYSA-N

物化性质

• 熔点：
  103-104℃
• 沸点：
  136 °C(Press: 25 Torr)
• 密度：
  1.350

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.833
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2918199090
• WGK Germany：
  3
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H317,H319
• 储存条件：
  室温且干燥环境下使用。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-Hydroxycyclopentanecarboxylic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H301: Toxic if swallowed
P301+P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-Hydroxycyclopentanecarboxylic acid
CAS number: 16841-19-3

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C6H10O3
Molecular weight: 130.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
UN Number: UN2811 Class: 6.1 Packing group: III
Proper shipping name: TOXIC SOLIDS, ORGANIC, N.O.S. (1-Hydroxycyclopentanecarboxylic acid)

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-羟基-环戊甲酸 生成 环戊酸
  参考文献：
  名称：

  Wislicenus; Gaertner, Justus Liebigs Annalen der Chemie, 1893, vol. 275, p. 333

  摘要：

  DOI：
• 作为产物：
  描述：

  1-羟基环戊烷甲腈 在 盐酸 作用下， 生成 1-羟基-环戊甲酸
  参考文献：
  名称：

  Spirodiclofen and Spiromesifen – Novel Acaricidal and Insecticidal Tetronic Acid Derivatives with a New Mode of Action

  摘要：

  广谱杀螨剂斯比羧菲（BAJ2740，商品名：Envidor®）和斯比菌酯（BSN2060，商品名：Oberon®）对烟粉虱有额外优异的活性，均属于拜耳作物科学在1990年代发现的新化学类别——四酮酸衍生物。从除草剂PPO（原卟啉原氧化酶）化学开始的发现过程，导致产品的合成路线，以及对中间体的过程开发的一些见解。斯比羧菲和斯比菌酯具有新的作用方式（干扰脂质生物合成），不对任何抗性螨虫或烟粉虱野外种群产生交叉抗性，因此是抗性管理的宝贵工具。

  DOI：

  10.2533/000942903777678588

文献信息

• [EN] 4-SUBSTITUTED PYRANO[3,4,B]PYRAZINE KAPPA AGONISTS FOR TREATING DRUG DEPENDENCY<br/>[FR] AGONISTES PYRANO [3,4,B] PYRAZINE KAPPA 4-SUBSTITUÉS POUR LE TRAITEMENT DE LA PHARMACODÉPENDANCE
  申请人：UNIV ROCKEFELLER

  公开号：WO2020247599A1

  公开（公告）日：2020-12-10

  1-Phenylacetyl-8-aminohexahydro-2H-pyrano[3,4-b]pyrazines of formula I are disclosed. The compounds are kappa ligands and are useful to treat drug dependency.

  公开了化学式I的1-苯乙酰基-8-氨基六氢-2H-吡喃并[3,4-b]吡嗪。这些化合物是kappa配体，可用于治疗药物依赖。
• COMPOSITIONS AND METHODS FOR FORMING ARTICLES HAVING SILVER METAL
  申请人：Eastman Kodak Company

  公开号：US20180362547A1

  公开（公告）日：2018-12-20

  Electrically-conductive silver metal can be provided in a thin film or pattern on a substrate from a silver complex having reducing silver ions and represented by: (Ag + ) a (L) b (P) c (I) wherein L represents an α-oxy carboxylate; P represents a 5- or 6-membered N-heteroaromatic compound; a is 1 or 2; b is 1 or 2; and c is 1, 2, 3, or 4, provided that when a is 1, b is 1, and when a is 2, b is 2. The silver complex is mixed in a hydroxy-free, nitrile-containing aprotic solvent with a polymer that is either (i) a hydroxy-containing cellulosic polymer or (ii) a non-cellulosic acrylic polymer having a halo- or hydroxy-containing side chain. The reducible silver ions in the a thermally sensitive thin film or pattern can be thermally converted to electrically-conductive metallic silver under suitable heating conditions to provide a product article that can be used in various devices.

  电导银金属可由含还原银离子的银配合物以薄膜或图案的形式提供在基底上，其由下式表示： (Ag + ) a (L) b (P) c (I) 其中L代表α-氧基羧酸盐；P代表5或6成员的N-杂环化合物；a为1或2；b为1或2；c为1、2、3或4，条件是当a为1时，b为1，当a为2时，b为2。将银配合物与不含羟基、含腈的无质子溶剂中的聚合物混合，该聚合物为(i)含羟基的纤维素聚合物或(ii)具有卤素或含羟基侧链的非纤维素丙烯酸聚合物。在热敏感薄膜或图案中的可还原银离子可以在适当的加热条件下热转换为电导银金属，以提供可用作各种设备的产品物品。
• PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS
  申请人：Philippe Michel

  公开号：US20100028280A1

  公开（公告）日：2010-02-04

  The invention relates to a process for straightening keratin fibres, comprising: (i) a step in which a straightening composition containing at least two denaturing agents is applied to the keratin fibres, (ii) a step in which the temperature of the keratin fibres is raised, using a heating means, to a temperature of between 110 and 250° C.

  该发明涉及一种直发角蛋白纤维的拉直过程，包括：(i)将至少两种变性剂含有的拉直组合物涂抹到角蛋白纤维上的步骤，(ii)使用加热装置将角蛋白纤维的温度升高至110至250°C的步骤。
• [EN] NON-SYSTEMIC TGR5 AGONISTS<br/>[FR] AGONISTES DE TGR5 NON SYSTÉMIQUES
  申请人：ARDELYX INC

  公开号：WO2013096771A1

  公开（公告）日：2013-06-27

  Compounds of structure (I), or a stereoisomer, tautomer, pharmaceutically acceptable salt or prodrug thereof, wherein R1, R2, R3, R4, R8, R9, R10, R11, R12, A1, A2, X, Y and Z are as defined herein. Uses of such compounds as TGR5 antagonists and for treatment of various indications, including Type II diabetes meletus are also provided.

  结构(I)的化合物，或其立体异构体、互变异构体、药学上可接受的盐或前药，其中R1、R2、R3、R4、R8、R9、R10、R11、R12、A1、A2、X、Y和Z如本文所定义。提供了这些化合物作为TGR5拮抗剂的用途，以及用于治疗各种适应症，包括II型糖尿病。
• [EN] MONOBACTAMS<br/>[FR] MONOBACTAMES
  申请人：PFIZER

  公开号：WO2012073138A1

  公开（公告）日：2012-06-07

  The present invention is directed to a new class of monobactam derivatives and their use for treating bacterial infections.

  本发明涉及一类新的单环内酰胺衍生物及其用于治疗细菌感染的用途。